We are live on ! Find out more
ASPN icon

Aspen Aerogels

54 hedge funds and large institutions have $70.9M invested in Aspen Aerogels in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

2% more funds holding

Funds holding: 5354 (+1)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1.87% less ownership

Funds ownership: 75.32%73.45% (-1.9%)

13% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 16

32% less capital invested

Capital invested by funds: $105M → $70.9M (-$33.7M)

Holders
54
Holders Change
+1
Holders Change %
+1.89%
% of All Funds
1.35%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
9
Increased
14
Reduced
16
Closed
7
Calls
Puts
Net Calls
Net Calls Change

ASPN Hedge Fund Activity: Q4 2016 in Review

54 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q4 2016, worth a combined $70.9M — down 32% from $105M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ASPN positions and 7 closed out — a net gain of 2 holders — while 14 added to existing stakes and 16 trimmed.

The largest buyer was Ariel Investments, adding an estimated $4.55M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $16.2M sold.

  • 54 institutional investors held Aspen Aerogels (ASPN) as of Q4 2016, up from 53 in Q3 2016.
  • Funds reported $70.9M of Aspen Aerogels stock for Q4 2016, down 32% quarter-over-quarter.
  • 9 funds opened new Aspen Aerogels positions in Q4 2016 and 7 closed out, a net change of +2 holders.
  • The largest Aspen Aerogels buyer in Q4 2016 was Ariel Investments, an estimated $4.55M added.
  • The largest Aspen Aerogels seller in Q4 2016 was T. Rowe Price Associates, an estimated $16.2M sold.

Based on aggregated 13F filings for Q4 2016.